Brandinium

Trademark search for:

THERABIS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2015-10-23 — Application filed
  • 2015-10-27 — Application filed
  • 2015-10-28 — Application filed
  • 2016-02-16 — Assigned to examiner
  • 2016-02-18 — Assigned to examiner
  • 2016-02-22 — Final disposition recorded
  • 2016-02-22 — Final disposition recorded
  • 2016-02-22 — Final disposition recorded
  • 2016-08-15 — Teas revoke/app/change addr of atty/dom rep received
  • 2016-08-15 — Attorney/dom.rep.revoked and/or appointed
  • 2016-08-17 — Office action issued
  • 2016-08-25 — Assigned to lie
  • 2016-08-31 — Teas/email correspondence entered
  • 2016-08-31 — Correspondence received in law office
  • 2016-09-16 — Approved for pub - principal register
  • 2016-09-19 — Law office publication review completed
  • 2016-10-05 — Notification of notice of publication e-mailed
  • 2016-10-25 — Published for opposition
  • 2016-10-25 — Official gazette publication confirmation e-mailed
  • 2016-12-20 — Noa e-mailed - sou required from applicant
  • 2017-04-05 — Teas change of correspondence received
  • 2017-04-05 — Teas change of owner address received
  • 2017-04-05 — Applicant/correspondence changes (non-responsive) entered
  • 2017-05-12 — Teas request to divide received
  • 2017-05-12 — Teas statement of use received
  • 2017-05-12 — Divisional request received
  • 2017-05-12 — Use amendment filed
  • 2017-05-30 — Case assigned to intent to use paralegal
  • 2017-05-30 — Sou extension 1 filed
  • 2017-05-30 — Sou teas extension received
  • 2017-06-06 — Sou extension 1 granted
  • 2017-06-06 — Divisional processing complete
  • 2017-06-06 — Statement of use processing complete
  • 2017-06-07 — Notice of approval of extension request e-mailed
  • 2017-07-08 — Allowed principal register - sou accepted
  • 2017-07-11 — Notice of acceptance of statement of use e-mailed
  • 2017-08-15 — Registered-principal register
  • 2019-03-25 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-03-25 — Attorney/dom.rep.revoked and/or appointed
  • 2019-06-03 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-06-03 — Attorney/dom.rep.revoked and/or appointed
  • 2022-08-15 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2023-02-17 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-02-17 — Teas change of correspondence received
  • 2023-02-17 — Attorney/dom.rep.revoked and/or appointed
  • 2023-02-17 — Teas change of owner address received
  • 2023-02-17 — Applicant/correspondence changes (non-responsive) entered
  • 2024-03-01 — Cancelled sec. 8 (6-yr)
  • 2024-03-01 — Final status recorded

Owner Information

Therabis, LLC
Denver , CO
Therabis, LLC
Denver , CO
Therabis, LLC
Denver , CO

Correspondent

Claudia W. Stangle LEYDIG, VOIT & MAYER, LTD.
TWO PRUDENTIAL PLAZA, 180 N. STETSON AVE
SUITE 4900
CHICAGO, IL 60601

Filing Details

Filing Date:
2015-10-23
Status Date:
2024-03-01
Category:
Pharmaceuticals
Filing Year:
2015

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.